Evidence map›Paper›PMID 38179425›Full record

Trial reportFrontiers in cellular and infection microbiology2023

Personalized antibiotic selection in periodontal treatment improves clinical and microbiological outputs.

Miglė Žiemytė, Andrés Lopez-Roldan, Miguel Carda-Diéguez, Marta Reglero-Santaolaya, Ana Rodriguez, María D Ferrer, Alex Mira

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Assessment of antibiotic resistance inJournal of Indian Society of Periodontology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miglė ŽiemytėGenomics & Health Department, Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) Foundation, Valencia, Spain.
Andrés Lopez-RoldanDepartment of Stomatology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Miguel Carda-DiéguezGenomics & Health Department, Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) Foundation, Valencia, Spain.
Marta Reglero-SantaolayaDepartment of Stomatology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
Ana RodriguezDepartment of Stomatology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain.
María D FerrerGenomics & Health Department, Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) Foundation, Valencia, Spain.
Alex MiraGenomics & Health Department, Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) Foundation, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Periodontitis is a biofilm-mediated disease that is usually treated by non-surgical biofilm elimination with or without antibiotics. Antibiotic treatment in periodontal patients is typically selected empirically or using qPCR or DNA hybridization methods. These approaches are directed towards establishing the levels of different periodontal pathogens in periodontal pockets to infer the antibiotic treatment. However, current methods are costly and do not consider the antibiotic susceptibility of the whole subgingival biofilm. Methods: In the current manuscript, we have developed a method to culture subgingival samples Results: Antibiotic selection was different in over 80% of the cases. Clinical parameters such as periodontal pocket depth, attachment level, and bleeding upon probing improved in both groups. However, dental plaque was significantly reduced only in the group where antibiotics were selected according to the Discussion: The results of clinical and microbiological parameters, together with the reduced cost and low analysis time, support the use of the impedance system for improved individualized antibiotic selection.

Indexed as

Anti-Bacterial AgentsPeriodontitisBacteriaHumansPeriodontal PocketRNA, Ribosomal, 16SAnti-Bacterial AgentsRNA, Ribosomal, 16Santibiotic treatmentbiofilmsinfectionoral bacteriaperiodontitispersonalized medicinesubgingival plaquexCELLigence

Identifiers

PMID38179425
PMCPMC10765594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.